PRJNA576003
Gene expression of Palbociclib treated vs CDK6 silenced Ph+ ALL cell line (BV-173) by RNA sequencing
The goal of this study is to compare transcriptome profiling (RNA-seq) of BV173 (Ph+ ALL cell line) treated with a CDK4/CDK6 dual inhibitor Palbociclib vs CDK6 silencing in order to search forpathways that might be regulated through kinase-independent mechanisms.